Empower Advisory Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
94,747
+61,954
| +189% | +$6.65M | 0.03% | 161 |
|
|
2025
Q1 | $3.31M | Buy |
32,793
+22,005
| +204% | +$2.22M | 0.01% | 185 |
|
|
2024
Q4 | $964K | Sell |
10,788
-1,938
| -15% | -$173K | ﹤0.01% | 235 |
|
|
2024
Q3 | $1.07M | Sell |
12,726
-395
| -3% | -$33.1K | ﹤0.01% | 231 |
|
|
2024
Q2 | $1.01M | Sell |
13,121
-4
| -0% | -$308 | ﹤0.01% | 224 |
|
|
2024
Q1 | $899K | Buy |
13,125
+332
| +3% | +$22.7K | ﹤0.01% | 236 |
|
|
2023
Q4 | $740K | Buy |
12,793
+157
| +1% | +$9.08K | ﹤0.01% | 252 |
|
|
2023
Q3 | $667K | Buy |
12,636
+328
| +3% | +$17.3K | ﹤0.01% | 266 |
|
|
2023
Q2 | $666K | Sell |
12,308
-6
| -0% | -$325 | ﹤0.01% | 270 |
|
|
2023
Q1 | $612K | Buy |
+12,314
| New | +$612K | ﹤0.01% | 283 |
|